The management of clinically localised prostate cancer diagnosed after a PSA test remains controversial. Active surveillance is an option that can help ameliorate the negative effects of over-treatment of PSA-detected prostate cancer. The longer term outcomes of this approach compared … Continue reading
Prostate cancer care has changed in recent years out of concern for over-diagnosis and over-treatment. However, many patients continue to undergo some form of curative treatment, and there is a perception among clinicians that more aggressive treatments are being favoured. … Continue reading
The Prostate Cancer Foundation of Australia and Cancer Council Australia along with input from an expert advisory panel, which included Andrology Australia’s Director Prof Rob McLachlan, have developed national evidence-based clinical practice guidelines on PSA testing and early management of … Continue reading
The doctor says it’s time for you to have a PSA test. But what is the PSA test exactly?
Androgen deprivation therapy (ADT) is a common life-extending treatment for particular types of prostate cancer. However, ADT is associated with a range of significant side-effects that can have adverse psychological impacts on men and their partners. The aim of an … Continue reading
What would happen if the chemotherapy drug docetaxel was given at the same time as androgen deprivation therapy treatment for metastatic prostate cancer?
A recent study found that viewing a video-format decision aid reduced men’s interest in PSA screening, primarily those who were undecided prior to viewing the aid and more than half wanted to speak to their doctor about their decision.
Researchers have found that group exercise programs for men with prostate cancer may help reduce the effects of androgen deprivation therapy on men's sexuality
The treatment of metastatic prostate cancer has advanced significantly in recent years, says Medical Oncologist Dr Emma Beardsley.
Researchers found that a 6-month diet and physical activity plan can help reduce side-effects of androgen deprivation therapy treatment for prostate cancer.